Related Experiment Videos
Signal transduction defects in growth hormone insensitivity
P E Clayton1, J S Freeth, A J Whatmore
1Endocrine Science Research Group, University of Manchester, UK.
Acta Paediatrica (Oslo, Norway : 1992). Supplement
|April 2, 1999
Summary
Growth hormone (GH) insensitivity can occur without GHR mutations, involving distinct signaling defects. These GHBP-positive families offer insights into GH signal specificity and phenotype-genotype relationships.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- Growth hormone (GH) insensitivity is a complex endocrine disorder often linked to mutations in the GH receptor (GHR).
- However, some families exhibit GH insensitivity independent of GHR mutations, presenting as growth hormone binding protein (GHBP)-positive.
Observation:
- Two families with GHBP-positive GH insensitivity show distinct abnormalities in GH signal transduction pathways.
- Family H (classic Laron syndrome) has a defect near the GHR affecting both STAT and MAPK pathways.
- Family M exhibits a defect in MAPK activation but not STAT activation.
Findings:
- The studied children display GH insensitivity with defects exclusive to the GH signaling system, not GHR mutations.
- These findings differentiate specific signaling pathway impairments underlying GH insensitivity phenotypes.
Implications:
- Families with GHBP-positive GH insensitivity without GHR mutations serve as crucial models.
- Further research can elucidate the specificity of GH signal transduction.
- Understanding these defects clarifies the relationship between GH insensitivity phenotypes and specific signaling pathway abnormalities.